Related references
Note: Only part of the references are listed.Biological Therapy in Pediatric Inflammatory Bowel Disease A Systematic Review
Domenico Corica et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2017)
Long-term safety and efficacy of etanercept in children and adolescents with plaque psoriasis
Amy S. Paller et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2016)
Treatment of Moderate to Severe Pediatric Psoriasis: A Retrospective Case Series
Daniel M. Klufas et al.
PEDIATRIC DERMATOLOGY (2016)
Differential Drug Survival of Biologic Therapies for the Treatment of Psoriasis: A Prospective Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)
Richard B. Warren et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)
Ustekinumab in adolescent patients age 12 to 17 years with moderate-to-severe plaque psoriasis: Results of the randomized phase 3 CADMUS study
Ian Landells et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2015)
Biologic Response Modifiers and Pediatric Psoriasis
Fernanda Bellodi Schmidt et al.
PEDIATRIC DERMATOLOGY (2015)
Occurrence of adverse events in patients with JIA receiving biologic agents: long-term follow-up in a real-life setting
Maarit Tarkiainen et al.
RHEUMATOLOGY (2015)
Study design and baseline characteristics from a phase 3, randomized, double-blind study of adalimumab versus methotrexate treatment in pediatric patients with chronic plaque psoriasis
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2014)
Systemic Treatments for Severe Pediatric Psoriasis A Practical Approach
Ann L. Marqueling et al.
DERMATOLOGIC CLINICS (2013)
Etanercept treatment for children and adolescents with plaque psoriasis
Amy S. Paller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)